We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN icon
1326
Biohaven
BHVN
$2.43B
– –
-4,150
Closed -$227K
BL icon
1327
BlackLine
BL
$1.96B
– –
-3,456
Closed -$223K
CABO icon
1328
Cable One
CABO
$128M
– –
-726
Closed -$307K
CIM
1329
Chimera Investment
CIM
$964M
– –
-4,657
Closed -$64.4K
CVCO icon
1330
Cavco Industries
CVCO
$4.39B
– –
-510
Closed -$204K
DNA icon
1331
Ginkgo Bioworks
DNA
$489M
– –
-1,913
Closed -$88.8K
DRVN icon
1332
Driven Brands
DRVN
$2.09B
– –
-10,327
Closed -$163K
EVH icon
1333
Evolent Health
EVH
$519M
– –
-6,807
Closed -$223K
FHI icon
1334
Federated Hermes
FHI
$4.84B
– –
-6,757
Closed -$244K
FOXF icon
1335
Fox Factory Holding Corp
FOXF
$887M
– –
-6,095
Closed -$317K
GEF icon
1336
Greif
GEF
$4.8B
– –
-3,613
Closed -$249K
GEVO icon
1337
Gevo
GEVO
$415M
– –
-13,202
Closed -$10.1K
GO icon
1338
Grocery Outlet
GO
$1.16B
– –
-11,609
Closed -$334K
HI
1339
DELISTED
Hillenbrand
HI
– –
-4,272
Closed -$215K
HTZ icon
1340
Hertz
HTZ
$727M
– –
-15,909
Closed -$125K
IART icon
1341
Integra LifeSciences
IART
$1.31B
– –
-8,093
Closed -$287K
ICLR icon
1342
Icon
ICLR
$13.1B
– –
-4,123
Closed -$1.39M
IRWD icon
1343
Ironwood Pharmaceuticals
IRWD
$701M
– –
-14,229
Closed -$124K
KSS icon
1344
Kohl's
KSS
$2.06B
– –
-8,921
Closed -$260K
LEG icon
1345
Leggett & Platt
LEG
$1.26B
– –
-15,904
Closed -$305K
LNC icon
1346
Lincoln National
LNC
$8.33B
– –
-8,037
Closed -$257K
LPL icon
1347
LG Display
LPL
$3.34B
– –
-10,191
Closed -$41.8K
MDXG icon
1348
MiMedx Group
MDXG
$657M
– –
-15,337
Closed -$118K
MRVI icon
1349
Maravai LifeSciences
MRVI
$1.25B
– –
-10,297
Closed -$89.3K
MVST icon
1350
Microvast
MVST
$296M
– –
-11,896
Closed -$9.96K
52 53
54
55 56

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.